Title |
7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement?
|
---|---|
Published in |
PLOS ONE, October 2011
|
DOI | 10.1371/journal.pone.0026190 |
Pubmed ID | |
Authors |
Yoon Hong Choi, Mark Jit, Nigel Gay, Nick Andrews, Pauline A. Waight, Alessia Melegaro, Robert George, Elizabeth Miller |
Abstract |
The UK introduced the 7-valent pneumococcal conjugate vaccine (PCV7) into the national vaccination program in September 2006. Previous modelling assumed that the likely impact of PCV7 on invasive pneumococcal disease (IPD) would be similar to the US experience with PCV7. However, recent surveillance data show a more rapid replacement of PCV7 IPD cases by non-PCV7 IPD cases than was seen in the US. |
Mendeley readers
The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 3% |
France | 1 | 1% |
Colombia | 1 | 1% |
Kenya | 1 | 1% |
Italy | 1 | 1% |
Unknown | 69 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 20 | 27% |
Student > Ph. D. Student | 17 | 23% |
Student > Master | 10 | 13% |
Student > Bachelor | 5 | 7% |
Professor | 4 | 5% |
Other | 13 | 17% |
Unknown | 6 | 8% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 29 | 39% |
Agricultural and Biological Sciences | 13 | 17% |
Mathematics | 5 | 7% |
Social Sciences | 4 | 5% |
Immunology and Microbiology | 3 | 4% |
Other | 7 | 9% |
Unknown | 14 | 19% |